Larvol Delta - Certa-Therapeutics-Receives-EU-Orphan-Designation-for-FT011-a-GPR68-Inhibitor-Being-Developed-as-an-AntiFibrotic-Treatment-for-Systemic-Sclerosis

FT011 - Certa Therap, OccuRx

https://www.globenewswire.com/news-release/2024/07/22/2916275/0/en/Certa-Therapeutics-Receives-EU-Orphan-Designation-for-FT011-a-GPR68-Inhibitor-Being-Developed-as-an-Anti-Fibrotic-Treatment-for-Systemic-Sclerosis.html

Jul 22, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next